About the PTCTC
"To support research and education to improve the availability, safety, and efficacy of hematopoietic cell transplantation and other cellular therapeutics for children and adolescents.”
The PTCTC (formerly known as the Pediatric Blood and Marrow Transplant Consortium, PBMTC) was founded in 1992 and is the largest clinical trials group focused exclusively on blood and marrow transplants for children and adolescents.
Our consortium includes more than 100 pediatric centers in the United States, Canada, New Zealand, and Australia. We also have affiliated members located in Europe, Asia and South America. The PTCTC is a core member of the NIH-funded Blood and Marrow Transplant Clinical Trials Network (BMT CTN) and has a close collaborative relationship with the Children's Oncology Group (COG). Our group also collaborates with the American Society for Transplantation and Cellular Therapy (ASTCT) and the center for International Blood and Marrow Transplant Research (CIBMTR) by hosting a session at the annual TCT Transplantation & Cellular Therapy Meetings focused on the unique and specific needs of children and adolescents in BMT.
The PTCTC has clinical trials activities focused on the application of BMT for younger patients and works in concert with many of our industrial partners. As the largest forum focused on pediatric BMT, the PTCTC is committed to research that improves clinical outcomes of BMT in children and adolescents. By vigorously advocating for our patients and their families, we strive to increase awareness and resources for all of those who must undergo this life saving treatment.
Support the PTCTC
Your generous gift will help the PTCTC in making great strides to sustain studies, develop protocols, further education, and nurture young investigators. Your donation is tax deductible.